![Pamela A. Trail](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela A. Trail
No open positions remaining
Profile
Pamela A. Trail was the founder of Agl Biotechnology Consultants, founded in 2007, and served as Principal from 2007 to 2008.
Former jobs include Non-Executive Director at Oncoinvent ASA; Vice President-Oncology Strategy at Regeneron Pharmaceuticals, Inc. from 2010 to 2017; Chief Scientific Officer at Seagen, Inc. from 2006 to 2007; Vice President-Department-Protein Therapeutics at Bayer Healthcare LLC from 2000 to 2006; Chief Scientific Officer at Molecular Partners AG from 2018 to 2019; and Vice President-Oncology Research at MedImmune LLC from 2008 to 2010.
Education includes a doctorate from the University of Connecticut, conferred in 1983.
Former positions of Pamela A. Trail
| Companies | Position | End |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 2019-06-30 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-02-28 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 2009-12-31 |
Agl Biotechnology Consultants | Founder | 2007-12-31 |
| SEAGEN INC. | Chief Tech/Sci/R&D Officer | 2007-05-30 |
Training of Pamela A. Trail
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides healthcare and pharmaceutical medicines | Health Technology |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Agl Biotechnology Consultants |
- Stock Market
- Insiders
- Pamela A. Trail
